1,4-Butanediol

1,4-Butanediol

SCHEMBL60932

O=C(O)CS.O=C(O)CS.OCCCCO

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.55
FFAR1 O14842 1/20 0.55
FFAR4 Q5NUL3 1/20 0.55
CAMK2A Q9UQM7 1/20 0.53
FOLH1 Q04609 1/20 0.41
FNTA P49354 1/20 0.41
FNTB P49356 1/20 0.41
LMNA P02545 5/20 0.37
SLC22A6 Q4U2R8 1/20 0.37
TSHR P16473 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NFKB1 P19838 1/20 0.35
PMP22 Q01453 1/20 0.35
ALDH1A1 P00352 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ACE P12821 1/20 0.33
LDHA P00338 1/20 0.33
SRR Q9GZT4 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,4-Butanediol SCHEMBL31453278 1.00 GPR84 (0.55) GPR84FFAR1FFAR4CAMK2AFOLH1
1,4-Butanediol SCHEMBL451336 1.00 GPR84 (0.55) GPR84FFAR1FFAR4CAMK2AFOLH1
Thioglycolic Acid SCHEMBL97046 0.97 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AFOLH1
1,5-Pentanediol SCHEMBL11585670 0.97 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AFOLH1
Thioglycolic Acid SCHEMBL11235420 0.97 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AFOLH1
Thioglycolic Acid SCHEMBL7078844 0.97 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AFOLH1
1,6-Hexanediol SCHEMBL98428 0.97 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AFOLH1
1,6-Hexanediol SCHEMBL11399082 0.97 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AFOLH1
Thioglycolic Acid SCHEMBL96894 0.97 GPR84 (0.60) GPR84FFAR1FFAR4CAMK2AFOLH1
Thioglycolic Acid SCHEMBL98408 0.93 CAMK2A (0.53) GPR84FFAR1FFAR4CAMK2AFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 732 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260117456-A1 LCE-BASED ARTIFICIAL MUSCLE FIBER AND PREPARATION METHOD AND USE THEREOF NANJING DRUM TOWER HOSPITAL (CN) 2026-04-30 US claimed
US-20250243370-A1 POLYDIMETHYLSILOXANE SUPERAMPHIPHOBIC COATING, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF Beijing Tsd Semiconductor Co., Ltd. (CN) 2025-07-31 US claimed
EP-3275911-B1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS HOYA LENS THAILAND LTD (TH) 2025-07-02 EP claimed
WO-2025051416-A1 CROSSLINKABLE BASE FOR PRODUCING AN ANTI-CORROSION COATING FOR A METAL SURFACE, IN PARTICULAR FOR AERONAUTICS CY CERGY PARIS UNIVERSITE (FR) 2025-03-13 WO claimed
US-20250033015-A1 POLYDISULFIDE CORE-SHELL MICROCAPSULES FIRMENICH SA (CH) 2025-01-30 US claimed
EP-3357945-B1 ADHESIVE POLYMER AND MEDICAL ADHESIVE PATCH TEIKOKU SEIYAKU KK (JP) 2024-10-30 EP claimed
WO-2024188359-A1 POLYTHIOL COMPOSITION AND USE THEREOF 益丰新材料股份有限公司 2024-09-19 WO claimed
EP-4229111-B1 MULTIFUNCTIONAL EPOXY SYSTEMS AND USE THEREOF SALEWSKI WERNER H (DE) 2024-09-04 EP claimed
US-20240157322-A1 CROSSLINKED CORE-SHELL MICROCAPSULES FIRMENICH SA (CH) 2024-05-16 US claimed
EP-4313393-A1 CROSSLINKED CORE-SHELL MICROCAPSULES Firmenich SA (CH) 2024-02-07 EP claimed
US-10144796-B2 Polymerizable composition, optical member, plastic lens, and eyeglass lens HOYA LENS THAILAND LTD. (TH) 2018-12-04 US claimed
US-20180100033-A1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS HOYA LENS THAILAND LTD. (TH) 2018-04-12 US claimed
EP-2848641-B1 METHOD FOR PRODUCING RUBBER MOLDING NICHIAS CORP (JP) 2018-02-28 EP claimed
EP-3275911-A1 POLYMERIZABLE COMPOSITION, OPTICAL MEMBER, PLASTIC LENS, AND EYEGLASS LENS Hoya Lens Thailand Ltd. (TH) 2018-01-31 EP claimed
US-20150148495-A1 METHOD FOR PRODUCING RUBBER MOLDING NICHIAS CORPORATION (JP) 2015-05-28 US claimed
EP-2848641-A1 METHOD FOR PRODUCING RUBBER MOLDING Nichias Corporation (JP) 2015-03-18 EP claimed
US-8722810-B2 Modified high CIS conjugated diene copolymer and preparing method of the same CHI MEI CORPORATION (TW) 2014-05-13 US claimed
US-20130172492-A1 MODIFIED HIGH CIS CONJUGATED DIENE COPOLYMER AND PREPARING METHOD OF THE SAME CHI MEI CORPORATION (TW) 2013-07-04 US claimed
US-20070287033-A1 Magnetic recording medium FUJIFILM CORPORATION (JP) 2007-12-13 US claimed
US-4093780-A ESTERS AND POLYESTERS OF THIOGLYCOLIC ACID NORANDA MINES LIMITED (CA) 1978-06-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260117456-A1 LCE-BASED ARTIFICIAL MUSCLE FIBER AND PREPARATION METHOD AND USE THEREOF MYLK2, MYH10, TNNC1 GPR84 3653/4885FFAR1 2902/4885FFAR4 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.